[Malignant hemopathies and tumor lysis syndrome: a current topic].
Leverger
G
G
Le Guyader
N
N
D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins; D015275:Tumor Lysis Syndrome / Q000188:drug therapy / Q000209:etiology*; D014503:Urate Oxidase / Q000627:therapeutic use
D000963:Antimetabolites; D000970:Antineoplastic Agents; D011994:Recombinant Proteins; C469709:rasburicase; D014503:Urate Oxidase